GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (OTCPK:TRGNF) » Definitions » Repurchase of Stock

TRGNF (Transgene) Repurchase of Stock : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Transgene Repurchase of Stock?

Transgene's Repurchase of Stock for the six months ended in Jun. 2024 was $0.00 Mil.

Transgene's Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

Transgene Repurchase of Stock Historical Data

The historical data trend for Transgene's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Repurchase of Stock Chart

Transgene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Transgene Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Transgene Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgene Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of Transgene's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Transgene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (OTCPK:TRGNF) » Definitions » Repurchase of Stock
Comparable Companies
XPAR:ADOC XPAR:MAAT XPAR:IVA XPAR:DBV XPAR:ABNX XPAR:SIGHT XPAR:NANO XPAR:ALGEN XPAR:ALCLS XPAR:ALGAE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY XKRX:068270 BNTX BGNE
Traded in Other Exchanges
0OCQ:UK TNG:France TGNA:Germany
Address
400 Boulevard Gonthier d’Andernach, Parc d’Innovation, Illkirch-Graffenstaden, FRA, 67400
Website
https://www.transgene.fr
Transgene SA is a biotechnology company. The Company conducts its business exclusively in the clinical research and development of therapeutic vaccines and immunotherapeutic products. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products. The majority of its operations is located in France.